Literature DB >> 15799546

Breaking the news in amyotrophic lateral sclerosis.

Adriano Chiò1, Gian Domenico Borasio.   

Abstract

Diagnosis communication is a mainstay of the patient-physician relationship and in ALS represents the beginning of the treatment. In Europe, the diagnosis is now communicated to most patients, but with some differences from north to south. Communication is the basis of the patient's autonomy. When adequately informed, patients are able to consider their preferences about life-extending interventions. However, this discussion is sometimes entertained too late. Both the style and the context of this discussion have profound impact on patient satisfaction. The content of the communication should include all relevant information about the disease and should be performed honestly while preserving hope. Collusion with relatives can create difficulties in the relationship with a patient and isolate them from their family. Diagnostic communication is an ongoing process and should form part of every follow-up visit. Communication with the dying patient is often reinforced by non-verbal messages, acknowledgements of patients' emotions, and by listening. Written material may increase satisfaction of patients and their relatives, but should never substitute for face-to-face discussion.

Entities:  

Keywords:  Professional Patient Relationship

Mesh:

Year:  2004        PMID: 15799546     DOI: 10.1080/14660820310017326

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  9 in total

Review 1.  The role of palliative care in patients with neurological diseases.

Authors:  Gian Domenico Borasio
Journal:  Nat Rev Neurol       Date:  2013-04-02       Impact factor: 42.937

2.  Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy.

Authors:  Vittorio Govoni; Edward Cesnik; Ilaria Casetta; Valeria Tugnoli; Maria Rosaria Tola; Enrico Granieri
Journal:  J Neurol       Date:  2012-01-10       Impact factor: 4.849

3.  Incidence of amyotrophic lateral sclerosis in Europe.

Authors:  Giancarlo Logroscino; Bryan J Traynor; Orla Hardiman; Adriano Chiò; Douglas Mitchell; Robert J Swingler; Andrea Millul; Emma Benn; Ettore Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-25       Impact factor: 10.154

4.  Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals.

Authors:  Anne Hogden; David Greenfield; Peter Nugus; Matthew C Kiernan
Journal:  Patient Prefer Adherence       Date:  2012-09-27       Impact factor: 2.711

5.  Lung volume recruitment improves volitional airway clearance in amyotrophic lateral sclerosis.

Authors:  Stuart Cleary; John E Misiaszek; Sonya Wheeler; Sanjay Kalra; Shelagh K Genuis; Wendy S Johnston
Journal:  Muscle Nerve       Date:  2021-09-28       Impact factor: 3.852

6.  From first symptoms to diagnosis of amyotrophic lateral sclerosis: perspectives of an Irish informal caregiver cohort-a thematic analysis.

Authors:  Miriam Galvin; Rebecca Gaffney; Bernie Corr; Iain Mays; Orla Hardiman
Journal:  BMJ Open       Date:  2017-03-20       Impact factor: 2.692

Review 7.  Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives.

Authors:  Elisabeth G Celius; Heidi Thompson; Maija Pontaga; Dawn Langdon; Alice Laroni; Stanca Potra; Trishna Bharadia; David Yeandle; Jane Shanahan; Pieter van Galen; Nektaria Alexandri; Jürg Kesselring
Journal:  Patient Prefer Adherence       Date:  2021-01-08       Impact factor: 2.711

8.  Overcoming therapeutic nihilism. Breaking bad news of amyotrophic lateral sclerosis-a patient-centred perspective in rare diseases.

Authors:  Stanisław Maksymowicz; Maria Libura; Paulina Malarkiewicz
Journal:  Neurol Sci       Date:  2022-02-12       Impact factor: 3.830

9.  Photovoice as a Participatory Research Tool in Amyotrophic Lateral Sclerosis.

Authors:  Adrianna Gunton; Gregory Hansen; Kerri Lynn Schellenberg
Journal:  J Neuromuscul Dis       Date:  2021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.